Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine as add-on to metformin (with or without sulfonylureas) in insulin-naive patients with type 2 diabetes (SUSTAIN 4): a randomised, open-label, parallel-group, multicentre, multinational, phase 3a trial. The Lancet Diabetes & Endocrinology, vol
Nutritional shifts during reduced intake may also play a role, especially if intake becomes insufficient
Oral semaglutide offers a mechanism that supports appetite regulation and metabolic balance, making it suitable for patients who require more than lifestyle modification alone to achieve progress
Experience better health outcomes with Wegovy, Oral Wegovy, Zepbound, or Foundayo
Safety and effective usage come from medical supervision and adherence to prescribed doses
It's used off-label by athletes and in clinical research